We are live on ! Find out more
ORGS

Orgenesis Inc. Common Stock
ORGS

Delisted

ORGS was delisted on the 18th of October, 2024.

Back to rankings

10 hedge funds and large institutions have $200K invested in Orgenesis Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+10
Holders Change %
–
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$120K
2
PAM
Panagora Asset Management
Massachusetts
+$54.8K
3
Citigroup
Citigroup
New York
+$15.4K
4
Bank of America
Bank of America
North Carolina
+$12.5K
5
WEC
Winslow Evans & Crocker
Massachusetts
+$11.8K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$104K +$120K +1,013 New
PAM
2
Panagora Asset Management
Massachusetts
$47K +$54.8K +463 New
Citigroup
3
Citigroup
New York
$13K +$15.4K +130 New
Bank of America
4
Bank of America
North Carolina
$11K +$12.5K +106 New
WEC
5
Winslow Evans & Crocker
Massachusetts
$10.3K +$11.8K +100 New
UBS Group
6
UBS Group
Switzerland
$6K +$5.8K +49 New
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$5K +$5.92K +50 New
SFG
8
SevenBridge Financial Group
Pennsylvania
$3K +$2.96K +25 New
SP
9
SWS Partners
Ohio
$1K +$1.42K +12 New
RFM
10
Royal Fund Management
Florida
– +$473 +4 New

ORGS Hedge Fund Activity: Q1 2018 in Review

10 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q1 2018, worth a combined $200K.

Buyers outnumbered sellers: 10 funds opened new ORGS positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $120K.

  • 10 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q1 2018, up from 0 in Q4 2017.
  • Funds reported $200K of Orgenesis Inc. Common Stock stock for Q1 2018.
  • 10 funds opened new Orgenesis Inc. Common Stock positions in Q1 2018 and 0 closed out, a net change of +10 holders.
  • The largest Orgenesis Inc. Common Stock buyer in Q1 2018 was Morgan Stanley, an estimated $120K added.

Based on aggregated 13F filings for Q1 2018.